GPX4 and cancer: Several reports demonstrated that ferroptosis is induced by loss of GPx4 activity due to the depletion of intracellular glutathione via the anti-cancer drug Erastin-mediated inhibition of the xCT cysteine transporter37, or by direct binding of RSL3 to selenocysteine in the GPx4 enzymatic active site8.